Davita Healthcare Partners Inc (DVA) 64.78 $DVA
Next Support Level for DaVita (DVA) is $63.58
Comtex SmarTrend(R) - Thu Sep 01, 9:21AM CDT
Shares of DaVita (NYSE
VA) opened today below their pivot of $64.54 and have already reached the first level of support at $64.11. Analysts will be watching for a cross of the next downside pivot targets of $63.58 and $62.62.
DVA: 64.78 (+0.59)
The Everett Clinic Announces Leadership Transitions
PR Newswire - Tue Aug 30, 10:00AM CDT
The Everett Clinic, a division of DaVita HealthCare Partners (NYSE: DVA), today announced two transitions among its senior leadership. As of Sept. 1, Rick Cooper will be the northwest regional market president for DaVita HealthCare Partners and Chris Knapp will be The Everett Clinic's chief executive officer.
DVA: 64.78 (+0.59)
DaVita Kidney Care Welcomes Dr. Bryan Becker to Physician Leadership Team
PR Newswire - Tue Aug 30, 7:13AM CDT
DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA), and a leading independent provider of integrated health and kidney care services in the United States, welcomes Bryan Becker, MD, MMM, FACP, CPE as vice president of integrated care and member of the Office of the Chief Medical Officer, DaVita's physician leadership team. Dr. Becker will lead the clinical programs for VillageHealth at DaVita HealthCare Partners.
DVA: 64.78 (+0.59)
DaVita Celebrates Recent Awards
PR Newswire - Thu Aug 25, 2:13PM CDT
DaVita HealthCare Partners (NYSE: DVA), a leading independent medical group and a leading provider of kidney care services announced recent awards recognizing the company's commitment to teammates, training and the health care community.
DVA: 64.78 (+0.59)
DaVita Kidney Care Welcomes Dr. Jeff Giullian to Physician Leadership Team
PR Newswire - Tue Aug 23, 5:12AM CDT
DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA), and a leading independent provider of integrated health and kidney care services in the United States, welcomes Jeffrey Allen Giullian, MD, MBA, as a vice president of medical affairs and member of the Office of the Chief Medical Officer, DaVita's physician leadership team. Dr. Giullian will hold the position of national group medical director and will also be the clinical leader for the Hospital Services Group.
DVA: 64.78 (+0.59)
NVIDIA, DaVita HealthCare Partners, Cisco Systems, L Brands and NetApp highlighted as Zacks Bull and Bear of the Day
Zacks Equity Research - Zacks Investment Research - Thu Aug 18, 8:30AM CDT
NVIDIA, DaVita HealthCare Partners, Cisco Systems, L Brands and NetApp highlighted as Zacks Bull and Bear of the Day
DVA: 64.78 (+0.59), L: 41.63 (+0.32), NTAP: 34.90 (-0.03), CSCO: 31.83 (+0.25), NVDA: 62.53 (-0.62)
Bear of the Day: DaVita HealthCare Partners (DVA)
Kevin Cook - Zacks Investment Research - Thu Aug 18, 8:16AM CDT
Bear of the Day: DaVita HealthCare Partners (DVA)
DVA: 64.78 (+0.59)
DaVita (DVA) Continues to Underperform: Time to Offload it?
Zacks Equity Research - Zacks Investment Research - Wed Aug 17, 8:53AM CDT
On Aug 17, 2016, we issued an updated research report on DaVita HealthCare Partners Inc. (DVA)
USPH: 64.10 (+0.98), AFAM: 36.63 (+0.22), DVA: 64.78 (+0.59), RDNT: 7.00 (+0.27)
DaVita Hospital Services Receives Re-Accreditation from The Joint Commission
PR Newswire - Wed Aug 17, 5:15AM CDT
DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA), and a leading independent provider of integrated health and kidney care services in the United States, today announced that DaVita Hospital Services has been re-accredited for Ambulatory Health Care from The Joint Commission effective 2016.
DVA: 64.78 (+0.59)
Healthcare Stocks Under Scanner -- Humana, Cigna, Molina Healthcare, and DaVita HealthCare Partners
PR Newswire - Wed Aug 10, 7:00AM CDT
The Healthcare sector rose 0.6%, outperforming the other sectors on Tuesday, August 09, 2016. Stock-Callers.com looks at how the following four equities fared at the close: Humana Inc. (NYSE: HUM), Cigna Corp. (NYSE: CI), Molina Healthcare Inc. (NYSE: MOH), and DaVita HealthCare Partners Inc. (NYSE: DVA). You can access of our complimentary research reports on these stocks now at: http://stock-callers.com/registration
CI: 128.18 (+0.54), DVA: 64.78 (+0.59), MOH: 55.33 (+1.79), HUM: 177.33 (+0.80)
DaVita (DVA) Tops Q2 Earnings & Revenues, Revises Outlook
Zacks Equity Research - Zacks Investment Research - Tue Aug 09, 9:31AM CDT
DaVita HealthCare Partners Inc. (DVA) reported second-quarter 2016 adjusted operating earnings of $1.01 per share that surpassed the Zacks Consensus Estimate
ANTM: 124.24 (+0.88), DVA: 64.78 (+0.59), MOH: 55.33 (+1.79), HUM: 177.33 (+0.80)
Watch for DaVita to Potentially Rebound After Falling 1.68% Yesterday
Comtex SmarTrend(R) - Mon Aug 08, 3:54PM CDT
DaVita (NYSE VA) traded in a range yesterday that spanned from a low of $75.32 to a high of $76.94. Yesterday, the shares fell 1.7%, which took the trading range below the 3-day low of $75.73 on volume of 488,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
DVA: 64.78 (+0.59)
DaVita Set to Possibly Rebound After Yesterday's Selloff of 1.68%
Comtex SmarTrend(R) - Mon Aug 08, 3:52PM CDT
DaVita (NYSE VA) traded in a range yesterday that spanned from a low of $75.32 to a high of $76.94. Yesterday, the shares fell 1.7%, which took the trading range below the 3-day low of $75.73 on volume of 488,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
DVA: 64.78 (+0.59)
DaVita HealthCare Partners Inc. 2nd Quarter 2016 Results
PR Newswire - Mon Aug 08, 3:01PM CDT
DaVita HealthCare Partners Inc. (NYSE: DVA) today announced results for the quarter ended June 30, 2016. Net income attributable to DaVita HealthCare Partners Inc. for the three months ended June 30, 2016 was $53 million, or $0.26 per share, which included goodwill impairment charges related to certain HCP reporting units, a gain on the partial sale of HCP's Tandigm Health (Tandigm) ownership interest and a loss on the sale of our HCP Arizona business as discussed below. Adjusted net income attributable to DaVita HealthCare Partners Inc. for the three months ended June 30, 2016 excluding these items was $210 million, or $1.01 per share.
DVA: 64.78 (+0.59)
Will Q2 Earnings Hold a Surprise for Davita (DVA) Stock?
Zacks Equity Research - Zacks Investment Research - Fri Aug 05, 9:14AM CDT
DaVita HealthCare Partners Inc. (DVA) is set to report second-quarter 2016 results after the market closes on Aug 8.
DVA: 64.78 (+0.59), ADHD: 4.77 (+0.03), AST: 2.96 (+0.14), ALQA: 0.89 (+0.02)
Healthcare Stocks' Q2 Earnings on Aug 8: BKD, BIOS, DVA
Zacks Equity Research - Zacks Investment Research - Fri Aug 05, 7:40AM CDT
Here, we take a look at three healthcare stocks scheduled to report their second-quarter figures on Aug 8.
DVA: 64.78 (+0.59), BIOS: 2.64 (+0.07), BKD: 17.60 (+0.61)
DaVita Falls 1.96% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Wed Jul 27, 3:34PM CDT
DaVita (NYSE VA) traded in a range yesterday that spanned from a low of $76.59 to a high of $78.00. Yesterday, the shares fell 2.0%, which took the trading range below the 3-day low of $77.40 on volume of 721,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
DVA: 64.78 (+0.59)
SmarTrend Watching for Potential Rebound in Shares of DaVita After 1.96% Loss
Comtex SmarTrend(R) - Wed Jul 27, 3:33PM CDT
DaVita (NYSE VA) traded in a range yesterday that spanned from a low of $76.59 to a high of $78.00. Yesterday, the shares fell 2.0%, which took the trading range below the 3-day low of $77.40 on volume of 721,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
DVA: 64.78 (+0.59)
DaVita HealthCare Partners Receives Multiple Honors from Leading Coordinated Care Association
PR Newswire - Mon Jun 20, 5:04AM CDT
DaVita HealthCare Partners Inc. (NYSE: DVA), a leading independent medical group in the United States and leading global provider of kidney care services, today announced that its medical group division, HealthCare Partners, received multiple honors from CAPG, the nation's leading organization for physician groups practicing coordinated care.
DVA: 64.78 (+0.59)
Next Support Level for DaVita (DVA) is $63.58
Comtex SmarTrend(R) - Thu Sep 01, 9:21AM CDT
Shares of DaVita (NYSE
VA) opened today below their pivot of $64.54 and have already reached the first level of support at $64.11. Analysts will be watching for a cross of the next downside pivot targets of $63.58 and $62.62. DVA: 64.78 (+0.59)
The Everett Clinic Announces Leadership Transitions
PR Newswire - Tue Aug 30, 10:00AM CDT
The Everett Clinic, a division of DaVita HealthCare Partners (NYSE: DVA), today announced two transitions among its senior leadership. As of Sept. 1, Rick Cooper will be the northwest regional market president for DaVita HealthCare Partners and Chris Knapp will be The Everett Clinic's chief executive officer.
DVA: 64.78 (+0.59)
DaVita Kidney Care Welcomes Dr. Bryan Becker to Physician Leadership Team
PR Newswire - Tue Aug 30, 7:13AM CDT
DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA), and a leading independent provider of integrated health and kidney care services in the United States, welcomes Bryan Becker, MD, MMM, FACP, CPE as vice president of integrated care and member of the Office of the Chief Medical Officer, DaVita's physician leadership team. Dr. Becker will lead the clinical programs for VillageHealth at DaVita HealthCare Partners.
DVA: 64.78 (+0.59)
DaVita Celebrates Recent Awards
PR Newswire - Thu Aug 25, 2:13PM CDT
DaVita HealthCare Partners (NYSE: DVA), a leading independent medical group and a leading provider of kidney care services announced recent awards recognizing the company's commitment to teammates, training and the health care community.
DVA: 64.78 (+0.59)
DaVita Kidney Care Welcomes Dr. Jeff Giullian to Physician Leadership Team
PR Newswire - Tue Aug 23, 5:12AM CDT
DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA), and a leading independent provider of integrated health and kidney care services in the United States, welcomes Jeffrey Allen Giullian, MD, MBA, as a vice president of medical affairs and member of the Office of the Chief Medical Officer, DaVita's physician leadership team. Dr. Giullian will hold the position of national group medical director and will also be the clinical leader for the Hospital Services Group.
DVA: 64.78 (+0.59)
NVIDIA, DaVita HealthCare Partners, Cisco Systems, L Brands and NetApp highlighted as Zacks Bull and Bear of the Day
Zacks Equity Research - Zacks Investment Research - Thu Aug 18, 8:30AM CDT
NVIDIA, DaVita HealthCare Partners, Cisco Systems, L Brands and NetApp highlighted as Zacks Bull and Bear of the Day
DVA: 64.78 (+0.59), L: 41.63 (+0.32), NTAP: 34.90 (-0.03), CSCO: 31.83 (+0.25), NVDA: 62.53 (-0.62)
Bear of the Day: DaVita HealthCare Partners (DVA)
Kevin Cook - Zacks Investment Research - Thu Aug 18, 8:16AM CDT
Bear of the Day: DaVita HealthCare Partners (DVA)
DVA: 64.78 (+0.59)
DaVita (DVA) Continues to Underperform: Time to Offload it?
Zacks Equity Research - Zacks Investment Research - Wed Aug 17, 8:53AM CDT
On Aug 17, 2016, we issued an updated research report on DaVita HealthCare Partners Inc. (DVA)
USPH: 64.10 (+0.98), AFAM: 36.63 (+0.22), DVA: 64.78 (+0.59), RDNT: 7.00 (+0.27)
DaVita Hospital Services Receives Re-Accreditation from The Joint Commission
PR Newswire - Wed Aug 17, 5:15AM CDT
DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA), and a leading independent provider of integrated health and kidney care services in the United States, today announced that DaVita Hospital Services has been re-accredited for Ambulatory Health Care from The Joint Commission effective 2016.
DVA: 64.78 (+0.59)
Healthcare Stocks Under Scanner -- Humana, Cigna, Molina Healthcare, and DaVita HealthCare Partners
PR Newswire - Wed Aug 10, 7:00AM CDT
The Healthcare sector rose 0.6%, outperforming the other sectors on Tuesday, August 09, 2016. Stock-Callers.com looks at how the following four equities fared at the close: Humana Inc. (NYSE: HUM), Cigna Corp. (NYSE: CI), Molina Healthcare Inc. (NYSE: MOH), and DaVita HealthCare Partners Inc. (NYSE: DVA). You can access of our complimentary research reports on these stocks now at: http://stock-callers.com/registration
CI: 128.18 (+0.54), DVA: 64.78 (+0.59), MOH: 55.33 (+1.79), HUM: 177.33 (+0.80)
DaVita (DVA) Tops Q2 Earnings & Revenues, Revises Outlook
Zacks Equity Research - Zacks Investment Research - Tue Aug 09, 9:31AM CDT
DaVita HealthCare Partners Inc. (DVA) reported second-quarter 2016 adjusted operating earnings of $1.01 per share that surpassed the Zacks Consensus Estimate
ANTM: 124.24 (+0.88), DVA: 64.78 (+0.59), MOH: 55.33 (+1.79), HUM: 177.33 (+0.80)
Watch for DaVita to Potentially Rebound After Falling 1.68% Yesterday
Comtex SmarTrend(R) - Mon Aug 08, 3:54PM CDT
DaVita (NYSE
VA) traded in a range yesterday that spanned from a low of $75.32 to a high of $76.94. Yesterday, the shares fell 1.7%, which took the trading range below the 3-day low of $75.73 on volume of 488,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion. DVA: 64.78 (+0.59)
DaVita Set to Possibly Rebound After Yesterday's Selloff of 1.68%
Comtex SmarTrend(R) - Mon Aug 08, 3:52PM CDT
DaVita (NYSE
VA) traded in a range yesterday that spanned from a low of $75.32 to a high of $76.94. Yesterday, the shares fell 1.7%, which took the trading range below the 3-day low of $75.73 on volume of 488,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion. DVA: 64.78 (+0.59)
DaVita HealthCare Partners Inc. 2nd Quarter 2016 Results
PR Newswire - Mon Aug 08, 3:01PM CDT
DaVita HealthCare Partners Inc. (NYSE: DVA) today announced results for the quarter ended June 30, 2016. Net income attributable to DaVita HealthCare Partners Inc. for the three months ended June 30, 2016 was $53 million, or $0.26 per share, which included goodwill impairment charges related to certain HCP reporting units, a gain on the partial sale of HCP's Tandigm Health (Tandigm) ownership interest and a loss on the sale of our HCP Arizona business as discussed below. Adjusted net income attributable to DaVita HealthCare Partners Inc. for the three months ended June 30, 2016 excluding these items was $210 million, or $1.01 per share.
DVA: 64.78 (+0.59)
Will Q2 Earnings Hold a Surprise for Davita (DVA) Stock?
Zacks Equity Research - Zacks Investment Research - Fri Aug 05, 9:14AM CDT
DaVita HealthCare Partners Inc. (DVA) is set to report second-quarter 2016 results after the market closes on Aug 8.
DVA: 64.78 (+0.59), ADHD: 4.77 (+0.03), AST: 2.96 (+0.14), ALQA: 0.89 (+0.02)
Healthcare Stocks' Q2 Earnings on Aug 8: BKD, BIOS, DVA
Zacks Equity Research - Zacks Investment Research - Fri Aug 05, 7:40AM CDT
Here, we take a look at three healthcare stocks scheduled to report their second-quarter figures on Aug 8.
DVA: 64.78 (+0.59), BIOS: 2.64 (+0.07), BKD: 17.60 (+0.61)
DaVita Falls 1.96% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Wed Jul 27, 3:34PM CDT
DaVita (NYSE
VA) traded in a range yesterday that spanned from a low of $76.59 to a high of $78.00. Yesterday, the shares fell 2.0%, which took the trading range below the 3-day low of $77.40 on volume of 721,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion. DVA: 64.78 (+0.59)
SmarTrend Watching for Potential Rebound in Shares of DaVita After 1.96% Loss
Comtex SmarTrend(R) - Wed Jul 27, 3:33PM CDT
DaVita (NYSE
VA) traded in a range yesterday that spanned from a low of $76.59 to a high of $78.00. Yesterday, the shares fell 2.0%, which took the trading range below the 3-day low of $77.40 on volume of 721,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion. DVA: 64.78 (+0.59)
DaVita HealthCare Partners Receives Multiple Honors from Leading Coordinated Care Association
PR Newswire - Mon Jun 20, 5:04AM CDT
DaVita HealthCare Partners Inc. (NYSE: DVA), a leading independent medical group in the United States and leading global provider of kidney care services, today announced that its medical group division, HealthCare Partners, received multiple honors from CAPG, the nation's leading organization for physician groups practicing coordinated care.
DVA: 64.78 (+0.59)
